Genie Energy Ltd., through its subsidiaries, provides energy services in the United States and internationally. It operates in two segments, Genie Retail Energy and Genie Renewables. The company resells electricity and natural gas to residential and small business customers in the Eastern and Midwestern United States and Texas; and develops, constructs, and operates utility-scale solar energy projects. It also distributes solar panels; offers energy procurement and advisory services to industrial, commercial, and municipal customers; and markets solar and alternative products and services. The company was incorporated in 2011 and is headquartered in Newark, New Jersey.

Genie Energy Ltd. Class B Stock

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and M...

Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)

Genesis Energy Limited ( ($NZ:GNE) ) has issued an update. Genesis Energy has confirmed it will release its financial results for the year ending 3...

Genesis Energy sets August date for FY26 results and investor webcast

Ganfeng Lithium Co ( ($HK:1772) ) has issued an announcement. Ganfeng Lithium Group Co., Ltd. held its 2025 annual general meeting on May 20, 2026,...

Ganfeng Lithium AGM Confirms Poll Results, Dividend Details and Board Changes

An announcement from Ganfeng Lithium Co ( ($HK:1772) ) is now available. Ganfeng Lithium Group Co., Ltd. has detailed the current composition of it...

Ganfeng Lithium details board composition and committee roles

Ganfeng Lithium Co ( ($HK:1772) ) just unveiled an update. Ganfeng Lithium Group has declared a final ordinary cash dividend for the financial year...

Ganfeng Lithium Declares Final 2025 Dividend for Hong Kong Shareholders

Genie Energy Ltd. Class B Commo (($GNE)) has held its Q1 earnings call. Read on for the main highlights of the call. Genie Energy’s latest earnings...

Genie Energy Earnings Call: Growth Meets Margin Squeeze

LifeSci Capital analyst Patrick Dolezal maintained a Buy rating on Neurogene today and set a price target of $60.00. Dolezal covers the Healthcare ...

LifeSci Capital Sticks to Its Buy Rating for Neurogene (NGNE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceut...

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY)

Ganfeng Lithium Co ( ($HK:1772) ) has provided an update. Ganfeng Lithium Group has announced a change of venue for its 2025 annual general meeting...

Ganfeng Lithium Shifts 2025 AGM Venue Without Changing Meeting Arrangements

Stifel Nicolaus analyst Paul Matteis reiterated a Buy rating on Neurogene today and set a price target of $46.00. Matteis covers the Healthcare sec...

Stifel Nicolaus Keeps Their Buy Rating on Neurogene (NGNE)

In a report released today, Tina Ting Hu from DBS maintained a Buy rating on Ganfeng Lithium Co, with a price target of HK$103.00. Ting Hu covers t...

New Buy Rating for Ganfeng Lithium Co (GNENF), the Basic Materials Giant

Ganfeng Lithium Co ( ($HK:1772) ) just unveiled an update. Ganfeng Lithium Group Co., Ltd. has issued a supplemental notice confirming that its 202...

Ganfeng Lithium Adds Guarantee Proposal to 2025 AGM Agenda

In a report released on May 1, Trina Chen from Goldman Sachs maintained a Sell rating on Ganfeng Lithium Co, with a price target of HK$60.00. Accor...

Goldman Sachs Reaffirms Their Sell Rating on Ganfeng Lithium Co (GNENF)

Ganfeng Lithium Co ( ($HK:1772) ) has issued an announcement. Ganfeng Lithium Group has completed the issuance of its 2026 first tranche green medi...

Market Cap	$391.33M	P/E Ratio	49.46
52W High	$28.47	52W Low	$13.19
Div Yield	30.0%	Payout Ratio	153.2%
EPS Growth 3Y	-23.8%	52W Position	4.3%
Overall Score	57	Value Score	100
Quality Score	52	Technical Score	20

EPS Current Est	$0.28	EPS Next Est	$0.34
EPS Growth Est	+21.4%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GNE	$13.85	-0.57%	28.18K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GNE	$13.85	-0.6%	28.18K
3
4
5
6

GNE

GNE

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Genie Energy Ltd. Class B Stock Data in Excel

Get Genie Energy Ltd. Class B Stock Data in Excel